Evidence map›Paper›PMID 21990224›Full record

ArticleHead & neck2011

Activating transcription factor-2 in survival mechanisms in head and neck carcinoma cells.

Dianne Duffey, Svetlana Dolgilevich, Sleiman Razzouk, Lina Li, Ross Green, Goutham Krishna Gorti

Open access · greenAbstract read
In one paragraph

Article in Head & neck, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy.Clinical cancer research : an official journal of the American Association for Cancer Research · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Dianne DuffeyYale University School of Medicine Section of Otolaryngology, 333 Cedar St, Box 208041, New Haven, Connecticut 06520, USA. Dianne.duffey@yale.edu
Svetlana Dolgilevich
Sleiman Razzouk
Lina Li
Ross Green
Goutham Krishna Gorti
Icahn School of Medicine at Mount Sinai · USYale University · USColumbia University · US

Funding

Mechanisms of ATF2 in Survival of Head and Neck CancerK22DE015835 · NIDCR · YALE UNIVERSITY · PI DUFFEY, DIANNE · 2004 to 2007
$540k
NIDCR NIH HHS K22 DE015835NIDCR NIH HHS K22DE015835
6 · The paper itself

Abstract

backgroundActivating transcription factor-2 (ATF2) is associated with tumor progression but is not well studied in head and neck squamous cell carcinoma (HNSCC). Its effects in stress and its importance in other survival mechanisms were studied.

methodsATF2 expression and nuclear activation were confirmed in HNSCC. After modulation of ATF2, in vitro effects on proliferation and chemosensitivity were studied. Effects on in vivo tumor growth and interleukin 8 (IL-8) expression were determined. Tumor necrosis factor-alpha (TNF-α) treatment was used to further evaluate cytokine production and chemosensitivity.

resultsReductions of ATF2 resulted in significant nuclear p-ATF2 activation, cisplatin resistance, and augmented IL-8 expression without affecting in vivo tumor growth. In this setting, TNF increases p-p38 phosphorylation and chemosensitivity while further enhancing IL-8 production.

conclusionOur data suggest regulatory roles for ATF2 in TNF-related mechanisms of HNSCC. Its perturbation and nuclear activation are associated with significant effects on survival and cytokine production.

Indexed as

Activating Transcription Factor 2ApoptosisBlotting, WesternCarcinoma, Squamous CellCell CycleCell ProliferationCisplatinCytokinesDrug Resistance, NeoplasmEnzyme-Linked Immunosorbent AssayGene Expression Regulation, NeoplasticHead and Neck NeoplasmsHumansImmunohistochemistryInterleukin-8In Vitro TechniquesActivating Transcription Factor 2CisplatinCytokinesInterleukin-8Tumor Necrosis Factor-alpha

Identifiers

PMID21990224
PMCPMC3117940
OpenAlexW2151157780

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.